Cargando…
Loss of Pancreatic E-Cadherin Causes Pancreatitis-Like Changes and Contributes to Carcinogenesis
BACKGROUND & AIMS: E-cadherin (Cdh1) is a key molecule for adherence required for maintenance of structural homeostasis. Loss of E-cadherin leads to poor prognosis and the development of resistance to chemotherapy in pancreatic cancer. Here, we evaluated the physiological and pathologic roles of...
Autores principales: | Kaneta, Yoshihiro, Sato, Takeshi, Hikiba, Yohko, Sugimori, Makoto, Sue, Soichiro, Kaneko, Hiroaki, Irie, Kuniyasu, Sasaki, Tomohiko, Kondo, Masaaki, Chuma, Makoto, Shibata, Wataru, Maeda, Shin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889596/ https://www.ncbi.nlm.nih.gov/pubmed/31526907 http://dx.doi.org/10.1016/j.jcmgh.2019.09.001 |
Ejemplares similares
-
NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice
por: Maeda, Shin, et al.
Publicado: (2021) -
c‐Jun N‐terminal kinase in pancreatic tumor stroma augments tumor development in mice
por: Sato, Takeshi, et al.
Publicado: (2017) -
Activation of Signal Transduction and Activator of Transcription 3 Signaling Contributes to Helicobacter-Associated Gastric Epithelial Proliferation and Inflammation
por: Ishii, Yasuaki, et al.
Publicado: (2018) -
Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy
por: Sue, Soichiro, et al.
Publicado: (2021) -
Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
por: Sugimori, Makoto, et al.
Publicado: (2019)